SEC Form 4 · accession 0001171843-26-004151
Edesa Biotech, Inc. · EDSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pardeep Nijhawan
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 16, 2026
Accepted (ET)
Jun 16, 2026 · 5:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001540159
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 16, 2026 | A | 153,550 | $5.21 | A | 884,684 | D | |
| Common SharesF2 | holding | — | — | — | 402,702 | I | Held by Pardeep Nijhawan Medicine Professional Corporation | |
| Common SharesF3 | holding | — | — | — | 32,609 | I | Held by The New Nijhawan Family Trust 2015 | |
| Common SharesF2 | holding | — | — | — | 32,013 | I | Held by The Digestive Health Clinic Inc. | |
| Common SharesF2 | holding | — | — | — | 53,104 | I | Held by 1968160Ontario Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50.
- F2Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F3Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.